NDC 71335-9712-09 - Phenazopyridine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-9712
- Requested NDC
- 71335-9712-09
- Package NDCs from labels
- 71335-9712-1, 71335-9712-2, 71335-9712-3, 71335-9712-4, 71335-9712-5, 71335-9712-6, 71335-9712-7, 71335-9712-8, 71335-9712-9, 71335-9712-09
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-12-12
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Phenazopyridine Hydrochloride - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-12-12 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-9712-1 | Phenazopyridine Hydrochloride | 20 in 1 BOTTLE | TABLET | 20 | 102 | |
| 71335-9712-2 | Phenazopyridine Hydrochloride | 12 in 1 BOTTLE | TABLET | 12 | 102 | |
| 71335-9712-3 | Phenazopyridine Hydrochloride | 9 in 1 BOTTLE | TABLET | 9 | 102 | |
| 71335-9712-4 | Phenazopyridine Hydrochloride | 10 in 1 BOTTLE | TABLET | 10 | 102 | |
| 71335-9712-5 | Phenazopyridine Hydrochloride | 15 in 1 BOTTLE | TABLET | 15 | 102 | |
| 71335-9712-6 | Phenazopyridine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | 102 | |
| 71335-9712-7 | Phenazopyridine Hydrochloride | 6 in 1 BOTTLE | TABLET | 6 | 102 | |
| 71335-9712-8 | Phenazopyridine Hydrochloride | 21 in 1 BOTTLE | TABLET | 21 | 102 | |
| 71335-9712-9 | Phenazopyridine Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 102 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-9712 | PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE) TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, 9 package rows | 20241226_7367afd6-6bf6-4240-a274-79b7a5de9715.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Artificial Tears 15 mL | POLYVINYL ALCOHOL, POVIDONE | Cardinal Health | 8cccc589-3a8e-baad-e053-2a95a90ab8c7 | 2026-09-09 | Warnings | FZ989GH94E |
| FRESHKOTE PRESERVATIVE FREE LUBRICANT EYE DROPS | POVIDONE, POLYVINYL ALCOHOL SOLUTION | Harrow Eye, LLC | 049e9cc9-0663-53bc-e063-6294a90a2c4f | 2026-09-04 | Warnings | FZ989GH94E |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 49baf6e5-133a-4e1a-9740-506673d27caf | 2026-08-21 | Warnings, Adverse reactions | 1094107 0EWG668W17 |
| Rohto Optic Glow | NAPHAZOLINE HYDROCHLORIDE, POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | df9c5f7c-96e6-4b2b-b8cb-21a6a3342dff | 2026-08-20 | Warnings | FZ989GH94E |
| Rohto All-In-One | HYPROMELLOSE, TETRAHYDROZOLINE HYDROCHLORIDE, ZINC SULFATE | The Mentholatum Company | 43e690e4-b381-46e3-838c-33aef5bdadde | 2026-08-20 | Warnings | 3NXW29V3WO |
| Rohto Preservative Free Dry Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | f4b1974c-2412-45f6-b79d-88b8a0bcb608 | 2026-08-18 | Warnings | FZ989GH94E |
| Rohto Dry-Aid | POVIDONE, PROPYLENE GLYCOL | The Mentholatum Company | 8ea5c6c9-48f4-406a-a2cb-9280c546d87d | 2026-08-18 | Warnings | FZ989GH94E |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | c0e5d32e-075f-4c76-8332-a06560001efe | 2026-08-14 | Adverse reactions | 1094104 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | Preferred Pharmaceuticals Inc. | 132cc592-6b03-4b75-bf39-df476fb9dc81 | 2026-08-14 | Adverse reactions | 1094107 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc | 96308f8c-66e7-486a-a5c0-ee9a133ad051 | 2026-08-14 | Warnings, Adverse reactions | 1094104 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | ce702be2-eec2-4346-965e-f1f6ba342fc9 | 2026-08-14 | Warnings, Adverse reactions | 1094107 0EWG668W17 |
| Dr. Shitong Photon Energy Eye Care Liquid | TETRAHYDROZOLINE HCL 0.05% HYPROMELLOSE 0.3% DR. SHITONG PHOTON ENERGY EYE CARE LIQUID | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 58ace434-55ef-17ef-e063-6294a90aa878 | 2026-08-10 | Warnings | 3NXW29V3WO |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE | REMEDYREPACK INC. | f6829698-b12e-484d-a322-d2f68586e637 | 2026-08-07 | Adverse reactions | 1094107 0EWG668W17 |
| Gencare-Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | Pioneer Life Sciences, LLC | 6bbf15b4-2954-40ff-8460-1ef0ed890654 | 2026-08-03 | Warnings | 0EWG668W17 |
| Nuvicare-Urinary Pain Relief Maximum Strength | PHENAZOPYRIDINE HYDROCHLORIDE | NUVICARE LLC | 5fe4e4dc-f1c4-4617-b6a6-6ea16a63abfe | 2026-08-03 | Warnings | 0EWG668W17 |
| Cystex Max Strength UTI Pain Relief | CYSTEX MAX STRENGTH UTI PAIN RELIEF | Clarion Brands LLC | 57482f71-80d3-b20d-e063-6394a90a0cf4 | 2026-07-27 | Warnings | 0EWG668W17 |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | REMEDYREPACK INC. | 6eb59b69-4ad0-47b1-bd3c-1d04d0852ec5 | 2026-07-27 | Warnings, Adverse reactions | 1094104 0EWG668W17 |
| GOOD NEIGHBOR PHARMACY ARTIFICAL TEARS LUBRICANT EYE DROPS | POLYVINYL ALCOHOL, POVIDONE | AmerisourceBergen | ce6852a8-c5e6-403d-a7b4-a2e85d1ebb1f | 2026-07-22 | Warnings | FZ989GH94E |
| Phenazopyridine Hydrochloride | PHENAZOPYRIDINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 56ad921f-0b6e-aa2b-e063-6394a90aec6b | 2026-07-15 | Warnings, Adverse reactions | 1094107 0EWG668W17 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.